abrdn Life Sciences Investors
 
 
 
 
基本資料
種類: ETF
費用比率%: 1.24
資產淨值: 18.78
成立日期: 08/05/1992
 
分析
市值分佈:
41.92%
大市值
28.32%
中市值
18.25%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 21/02/2026 06:08) 總持有投資項目: 78  
0%
 
100%
     10大 (28.22%)
代號 名稱 佔比% 持有日期
SIONSionna Therapeutics Inc1.4731/01/2026
BHVNBiohaven Ltd1.4631/01/2026
AXSMAxsome Therapeutics1.4131/01/2026
GPCRStructure Therapeutics1.3331/01/2026
TECXTectonic Therapeutic Inc.1.3231/01/2026
PRAXPraxis Precision Medicines1.3231/01/2026
EYPTEyePoint Inc.1.3031/01/2026
OCSOculis Holding AG1.2931/01/2026
TVTXTravere Therapeutics1.2531/01/2026
SNDXSyndax Pharmaceuticals1.2531/01/2026
NUVLNuvalent1.2331/01/2026
IDYAIDEAYA Biosciences1.2131/01/2026
ADPTAdaptive Biotechnologies Corp1.2031/01/2026
SPRYARS Pharmaceuticals1.0431/01/2026
SGEN0.9730/11/2023
NAMSNewAmsterdam Pharma Company NV0.9531/01/2026
GRALGRAIL Inc.0.9231/01/2026
IRONDisc Medicine0.8531/01/2026
TSHATaysha Gene Therapies0.8231/01/2026
GHGuardant Health0.8231/01/2026
  1   2    3    4  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.